Kanion Pharmaceutical (600557.SH) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Oct30

Kanion Pharmaceutical released FY2025 Q3 earnings on October 30 After-Market BJT, actual revenue CNY 701.11 M (forecast CNY 1.058 B), actual EPS CNY 0.1

01:00

Kanion Pharmaceutical released FY2025 9 Months earnings on October 30 After-Market BJT, actual revenue CNY 2.343 B, actual EPS CNY 0.3512

01:00

Oct23

Kanion Pharmaceutical to Release FY2025 Q3 Earnings on October 31 After-Market (BJT), Forecast Revenue CNY 1.058 B

01:07

Aug27

Kanion Pharmaceutical released FY2025 Semi-Annual earnings on August 27 After-Market (BJT), actual revenue CNY 1.642 B, actual EPS CNY 0.25

01:00

Kanion Pharmaceutical released FY2025 Q2 earnings on August 27 After-Market (BJT), actual revenue CNY 764.02 M (forecast CNY 1.347 B), actual EPS CNY 0.1011

01:00

Aug6

Kangyuan Pharmaceutical Adjusts Semi-annual Report Release Date and Responds to R&D Progress

11:31

Schedules & Filings

Schedules

Filings

Oct30

Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 701.11 M, Net Income 57.27 M, EPS 0.1

Aug28

Earning Release(CST)

FY2025 Semi-Annual Earning Release

Aug27

Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 764.02 M, Net Income 58.96 M, EPS 0.1011

View More

Stock List

Top Gainers

Top Decliners

Northbound Connect

Symbol

Price

%Chg

Change

View More